IPO
IPO
Best Performers
Forthcoming Issues
Closed Issues
New Listings
Current Issues
IPO Performance
IPO News
IPO Analysis
Basis of Allotment
Draft Prospectus
  HOME  >  IPO  >   IPO SNAPSHOT
IPO Snapshot    
Mahamaya Lifesciences Ltd.
Issue Open Date 11-Nov-25  
Issue Closing Date 13-Nov-25  
Application Money 100  
Allotment Money  
Price Band 108 - 114  
Minimium Application No. 2400  
Issue Size (Shares) 4426800  
Market Lot 1.00  
Objective
a. Purchase of Equipment for existing Formulation plantb. Funding capital expenditure towards setting up of a new Technical manufacturing plant.c. Construction of Warehouse Building and Purchase of Machineryd. Funding working capital requirement of our Companye. General Corporate purposes
Category No. of Shares No. of Shares Subscription Ratio
  Offered / Reserved Bid For  
Non-Institutional Investors   1191600   3514800   2.95  
Qualified Institutional Buyers   1176000   1401600   1.19  
Retail Individual Investors   2059200   2107200   1.02  
Business Description
Our company specializes in the manufacturing of pesticide formulations and supply bulk formulations catering to both Indian agrochemical companies, as well as multinational corporations (MNCs). We began our journey by focusing on import and registration of vit
more...
Promoter's Holding
Total Share Capital   13728000  
Offered to Public   4426800  
Promoter's Holding (Pre-Issue)   77.27  
Promoter's Holding (Post-Issue)   56.35  
Address
Unit No: D P T – 033
Ground Floor
Plot No: 79 – 80
Dlf Prime Tower
F – Block
Okhla
Phase – 1
New Delhi ,
Delhi ,
110020
Phone: 011-46561474
Email: cs@mahamayalifesciences.com
Website: https://www.mahamayalifesciences.com/home
Registrar
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B
Plot 31-32
Gachibowli
Financial District
Nanakramguda
Hyderabad
Listed at
BSE
Lead Manager
Oneview Corporate Advisors Pvt Ltd.
Promoters
Krishnamurthy Ganesan
Lalitha Krishnamurthy
Prashant Krishnamurthy
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.